FDA Inspection 1241697 — BioLife Plasma Services LP
The FDA completed an inspection of BioLife Plasma Services LP on May 10, 2024 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 10, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Augusta, GA (United States)